跳至主要内容
临床试验/NCT03804697
NCT03804697已完成不适用

Selective Thromboembolism Prophylaxis After Total Hip Arthroplasty or Total Knee Arthroplasty by a Risk Stratification With Thromboelastography for Asian Populations: A Randomized Control Trial

Guangdong Provincial People's Hospital0 个研究点目标入组 197 人开始时间: 2016年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
197
主要终点
The Incidence of Deep Vein Thrombosis

研究概览

简要总结

Asian populations have a lower rate of high-risk gene mutations of venous thrombosis, which means a reasonable perioperative anticoagulant management after hip or knee arthroplasty for Caucasian populations may be too excessive for Asians. So, individual patient risk assessment, rather than a "blanket policy", is considered the best thromboembolism prophylaxis for Asians.The purpose of this study was to evaluate the effectiveness and safety of selective thromboembolism prophylaxis compared with conventional thromboembolism prophylaxis by risk stratification with thromboelastography (TEG) after joint arthroplasty for Asian populations.

详细描述

Asian patients who underwent hip or knee arthroplasty in Guangdong General Hospital from August 2016 to August 2017 were randomly divided into selective anticoagulation group (SAG) and conventional anticoagulation group (CAG). SAG used anticoagulant when TEG indicated hypercoagulability while CAP used anticoagulant until one month after surgery regularly. Data including patients' basic information, postoperative complications, perioperative clotting index, intraoperative blood loss, perioperative TEG, volume of drainage, and blood transfusion were evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • over 18 years of age,
  • ASA Ⅰ-Ⅱ grade,
  • BMI <40Kg / M ^ 2
  • Underwent total knee arthroplasty/ total hip arthroplasty in Guangdong General Hospital
  • consent to enroll in this study

排除标准

  • history of VTE, preoperative infection, preoperative coagulation
  • liver and kidney function existed clinically abnormalities
  • history of tumor
  • history of vascular surgery
  • heart infarction or cerebral infarction within 6 months
  • history of lower extremity surgery within 3 months

研究组 & 干预措施

selective anticoagulation group

Experimental

Selective anticoagulation group used anticoagulant when thromboelastogram(TEG) indicated hypercoagulability.

TEG was performed 1 day before the surgery, 1 day after the surgery, 3 days after the surgery, and 5 days after the surgery.

The dosage regimen of anticoagulant was hypodermic injection 0.4 ml low molecular weight heparin per day for 5 days and oral administration of 10 mg Rivaroxaban until one month after the surgery.

干预措施: selective anticoagulation (Drug)

conventional anticoagulation group

Active Comparator

The Intervention for conventional anticoagulation group was using anticoagulant until one month after surgery routinely.

The dosage regimen of anticoagulant was hypodermic injection 0.4 ml low molecular weight heparin per day for 5 days and oral administration of 10 mg Rivaroxaban until one month after the surgery.

干预措施: selective anticoagulation (Drug)

结局指标

主要结局

The Incidence of Deep Vein Thrombosis

时间窗: 6 months after surgery

Measured by ultrasound

次要结局

  • Hematocrit(5 days after surgery)
  • Hemoglobin(5 days after surgery)
  • Red Blood Cell(5 days after surgery)
  • Volume of Transfusion(During Hospitalization)
  • Transfusion Rate(During Hospitalization)
  • Ecchymosis incidence Rate(1 month after surgery)
  • Superficial Infection(6 months after surgery)
  • Deep Infection(6 months after surgery)

研究者

申办方类型
Other
责任方
Sponsor

相似试验